Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?

To: Anthony Wong who wrote (7850)	6/10/1999 8:28:00 AM
From: Tunica Albuginea	Read Replies (1) \| Respond to of 9523

Anthony Wong, Goldman Sacks and other analysts downgrade PFE today as slower growth. PFE trsding at 102 premarket. Going to 90? TA Pfizer (PFE: news, msgs) shares dropped 2 15/16 to 102, according to Art Hogan, chief market analyst at Jefferies & Co, after being downgraded by Salomon Smith Barney. ABN AMRO also downgraded the drug maker, according to traders at S.G. Cowen. The drug maker said Wednesday it would warn physicians to limit use of its Trovan drug due to FDA reports that it was associated with liver failure. cbs.marketwatch.com